The persistent medical failure to treat sleep as a fundamental vital sign has created a massive blind spot in preventive healthcare that artificial intelligence is now attempting to illuminate. While physicians have long relied on snapshots like blood pressure and heart rate, the complex biological
Faisal Zain has spent years at the intersection of medical innovation and drug delivery, witnessing firsthand the evolution of how we approach chronic disease. As the biopharmaceutical landscape shifts toward the revolutionary concept of "immune resetting," he provides a unique
Navigating the High-Stakes World of Federal Health Regulation and Pharmaceutical Oversight The global pharmaceutical market, now valued at over one and a half trillion dollars, serves as the ultimate litmus test for the efficiency of federal regulatory oversight and the preservation of human
The silent deterioration of our internal energy systems has quietly become the primary architect of the global health crisis, manifesting as a collection of seemingly unrelated diseases. For decades, the medical establishment viewed heart disease, type 2 diabetes, and chronic kidney failure as
Faisal Zain has navigated the complex intersection of medical device innovation and digital health for years, witnessing firsthand how the industry struggles to turn fragmented data into life-saving treatments. As Big Tech players like Amazon and Google move deeper into the life sciences, the
Cervical cancer is on the brink of elimination in Australia, yet thousands of women still face stagnant survival when the diagnosis is uterine, ovarian, vulvar, vaginal, or placental, and that paradox now defines both the opportunity and the risk for a health system known for turning science into
